Research

Heart illustration
August 20, 2014

Study finds coronary arteries hold heart-regenerating cells

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered.

By Leigh MacMillan
August 20, 2014

Enzyme holds the door for influenza

Compounds developed at Vanderbilt University may offer a new way to block influenza infection.

By VUMC News and Communications
August 19, 2014

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

By Leigh MacMillan
August 15, 2014

Vanderbilt enrolling children with autism in medication-related weight gain study

Vanderbilt University is one of four sites in the United States and Canada to enroll children with autism in a study to examine weight gain commonly experienced while taking antipsychotic medication.

By VUMC News and Communications
August 15, 2014

Weight regain after gastric bypass

Early weight regain after gastric bypass surgery does not reverse metabolic improvements, and the “hunger hormone” ghrelin might indicate who is susceptible to weight regain.

By Leigh MacMillan
colorful x-ray of brain
August 14, 2014

Team takes 4-D look at brain receptor’s role

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory.

By Bill Snyder
August 14, 2014

Growth factor blockade targets breast tumors

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.
By VUMC News and Communications
August 13, 2014

High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
By Craig Boerner
August 7, 2014

Conn lands Javits Neuroscience Investigator award

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders.
By Bill Snyder
August 7, 2014

Novel treatment strengthens bones in genetic disease

An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.
By Leigh MacMillan
August 7, 2014

Study tracks new end-stage renal disease therapy

Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.
By Kathy Whitney
August 6, 2014

Low selenium and lung cancer

Vanderbilt researchers have found that selenium deficiency may contribute to the racial disparity in lung cancer incidence.
By Yan Su
August 5, 2014

Technique brings spinal cord neural signaling into focus

Researchers in the Vanderbilt University Institute of Imaging Science have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.
By Bill Snyder
1 … 146 147 148 149 150 … 216